Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Long-term health outcomes of a decision aid: data from a randomized trial of adjuvant! In women with localized breast cancer.

Vickers AJ, Elkin EB, Peele PB, Dickler M, Siminoff LA.

Med Decis Making. 2009 Jul-Aug;29(4):461-7. doi: 10.1177/0272989X08329344. Epub 2009 Mar 6.

2.

Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer.

Whelan T, Sawka C, Levine M, Gafni A, Reyno L, Willan A, Julian J, Dent S, Abu-Zahra H, Chouinard E, Tozer R, Pritchard K, Bodendorfer I.

J Natl Cancer Inst. 2003 Apr 16;95(8):581-7.

3.
4.

A decision aid to assist in adjuvant therapy choices for breast cancer.

Siminoff LA, Gordon NH, Silverman P, Budd T, Ravdin PM.

Psychooncology. 2006 Nov;15(11):1001-13.

PMID:
16511899
5.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

7.

Accuracy validation of adjuvant! online in Taiwanese breast cancer patients--a 10-year analysis.

Yao-Lung K, Dar-Ren C, Tsai-Wang C.

BMC Med Inform Decis Mak. 2012 Sep 17;12:108. doi: 10.1186/1472-6947-12-108.

9.

Offering a choice between two adjuvant chemotherapy regimens: a pilot study to develop a decision aid for women with breast cancer.

Irwin E, Arnold A, Whelan TJ, Reyno LM, Cranton P.

Patient Educ Couns. 1999 Jul;37(3):283-91.

PMID:
14528554
10.

LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.

Goel S, Sharma R, Hamilton A, Beith J.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004562. doi: 10.1002/14651858.CD004562.pub4. Review.

PMID:
19821328
11.
12.

Adjuvant therapy for breast cancer.

[No authors listed]

NIH Consens Statement. 2000 Nov 1-3;17(4):1-35. Review.

PMID:
11512506
13.

Hormonal therapies for early breast cancer: systematic review and economic evaluation.

Hind D, Ward S, De Nigris E, Simpson E, Carroll C, Wyld L.

Health Technol Assess. 2007 Jul;11(26):iii-iv, ix-xi, 1-134. Review.

14.

Is adjuvant therapy for older patients with node (+) early breast cancer cost-effective?

Naeim A, Keeler EB.

Breast Cancer Res Treat. 2005 Nov;94(2):95-103.

PMID:
16261407
15.

LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.

Sharma R, Hamilton A, Beith J.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD004562. doi: 10.1002/14651858.CD004562.pub3. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD004562.

PMID:
18843661
17.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
18.

Early breast cancer in the elderly: assessment and management considerations.

Albrand G, Terret C.

Drugs Aging. 2008;25(1):35-45. Review.

PMID:
18184027
19.

A demonstration of ''less can be more'' in risk graphics.

Zikmund-Fisher BJ, Fagerlin A, Ubel PA.

Med Decis Making. 2010 Nov-Dec;30(6):661-71. doi: 10.1177/0272989X10364244. Epub 2010 Apr 7.

20.

Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting.

Blohmer JU, Rezai M, Kümmel S, Kühn T, Warm M, Friedrichs K, Benkow A, Valentine WJ, Eiermann W.

J Med Econ. 2013;16(1):30-40. doi: 10.3111/13696998.2012.722572. Epub 2012 Sep 11.

PMID:
22966753
Items per page

Supplemental Content

Write to the Help Desk